Skip to content

H2020HORIZONFP7

Bayer Aktiengesellschaft

Country
DEGermany
Defence projects
0
Projects, all programmes
86
As coordinator
5
EU contribution (CORDIS)
EUR 4,898,800
Active
2012 to 2026

Projects

86 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
ONTOXOntology-driven and artificial intelligence-based repeated dose toxicity testing of chemicals for next generation risk assessmentH20202021ParticipantEUR 931,165
InPharmaA fully integrated, animal-free, end-to-end modelling approach to oral drug product developmentH20202021ParticipantEUR 252,788
OPTIMAOptimal treatment for patients with solid tumours in Europe through Artificial intelligenceH20202021ParticipantEUR 0
AGePOPDrug Absorption in Geriatric Patients and Older People: a training network innovating drug development for the advanced age populationH20202021ParticipantEUR 252,788
PERSIST-SEQBuilding a reproducible single-cell experimental workflow to capture tumour cell persistenceH20202021ParticipantEUR 0
SISAQOL-IMIEstablishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trialsH20202021ParticipantEUR 0
ENLIGHT-TENplusEuropean Network Linking Informatics and Genomics of Helper T cells in TissuesH20202021ParticipantEUR 252,788
T2EVOLVEAccelerating Development and Improving Access to CAR and TCR-engineered T cell therapyH20202021ParticipantEUR 0
REsolutionAdd medical genetic solutions to RESOLUTE (REsolution)H20202021ParticipantEUR 0
AIDDAdvanced machine learning for Innovative Drug DiscoveryH20202021ParticipantEUR 126,394
PharmaLedgerPharmaLedgerH20202020ParticipantEUR 0
HARMONY PLUSHEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUSH20202020ParticipantEUR 0
Gravitate-HealthGravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to TreatmentH20202020ParticipantEUR 0
PREMIERPrioritisation and Risk Evaluation of Medicines in the EnviRonmentH20202020ParticipantEUR 0
EUbOPENEUbOPEN: Enabling and Unlocking biology in the OPENH20202020ParticipantEUR 0
ARDATAccelerating Research & Development for Advanced TherapiesH20202020ParticipantEUR 0
CARECorona Accelerated R&D in EuropeH20202020ParticipantEUR 0
MOBILISE-DConnecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsementH20202019ParticipantEUR 0
Immune-ImageImmune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer StrategiesH20202019ParticipantEUR 0
TICARDIOThrombo-inflammation in cardiovascular diseaseH20202019PartnerEUR 0

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.